Jump Financial’s Fulgent Genetics FLGT Stock Holding History

Jump Financial’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.24M	Buy	109,300 +37,461	+52%	+$635K	0.02%	848
2026 Q1	$1.14M	Buy	71,839 +51,138	+247%	+$1.11M	0.02%	869
2025 Q4	$544K	Sell	20,701 -19,653	-49%	-$510K	0.01%	1282
2025 Q3	$912K	Sell	40,354 -49,646	-55%	-$1.02M	0.01%	1060
2025 Q2	$1.79M	Sell	90,000 -3,049	-3%	-$59.4K	0.02%	761
2025 Q1	$1.57M	Buy	93,049 +67,749	+268%	+$1.15M	0.02%	662
2024 Q4	$467K	Buy	+25,300	New	+$494K	0.01%	1108
2024 Q3	–	Sell	-20,920	Closed	-$410K	–	1797
2024 Q2	$410K	Sell	20,920 -11,281	-35%	-$236K	0.01%	1214
2024 Q1	$699K	Buy	+32,201	New	+$800K	0.02%	1002
2021 Q4	–	Sell	-10,299	Closed	-$927K	–	1490
2021 Q3	$927K	Sell	10,299 -1,978	-16%	-$180K	0.07%	308
2021 Q2	$1.13M	Buy	+12,277	New	+$980K	0.11%	245
2021 Q1	–	Sell	-8,050	Closed	-$419K	–	1048
2020 Q4	$419K	Buy	+8,050	New	+$336K	0.07%	447

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Financial's FLGT Position: Q2 2026 in Review

Jump Financial increased its Fulgent Genetics (FLGT) stake by 52% in Q2 2026, buying an estimated $635K and bringing the position to 109,300 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #848.

Jump Financial first reported a position in FLGT in Q4 2020 and has held it in 12 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

Jump Financial held 109,300 shares of Fulgent Genetics worth $2.24M as of Q2 2026.
Jump Financial bought 37,461 Fulgent Genetics shares in Q2 2026, an estimated $635K.
Fulgent Genetics made up 0.02% of Jump Financial's portfolio in Q2 2026, its #848 holding.
Jump Financial first reported a position in Fulgent Genetics in Q4 2020 and has held it in 12 quarters since.
142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.